4587 — PeptiDream Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for PeptiDream, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,677	9,422	26,852	28,712	46,677
Cost of Revenue
Gross Profit	9,529	7,029	18,113	17,219	34,504
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,642	5,356	17,872	21,939	25,563
Operating Profit	6,035	4,066	8,980	6,773	21,114
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,020	3,804	6,653	4,353	20,889
Provision for Income Taxes
Net Income After Taxes	4,448	2,573	7,554	3,036	15,015
Net Income Before Extraordinary Items
Net Income	4,448	2,573	7,554	3,036	15,015
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,448	2,573	7,554	3,036	15,015
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	39.8	19.8	58.1	23.6	117
Dividends per Share